Search

Eric Olson

Examiner (ID: 3855, Phone: (571)272-9051 , Office: P/1673 )

Most Active Art Unit
1623
Art Unit(s)
1623, 1693, 1673
Total Applications
1706
Issued Applications
961
Pending Applications
123
Abandoned Applications
631

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7111734 [patent_doc_number] => 20050209190 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Camptothecin complexes' [patent_app_type] => utility [patent_app_number] => 11/008633 [patent_app_country] => US [patent_app_date] => 2004-12-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 8540 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209190.pdf [firstpage_image] =>[orig_patent_app_number] => 11008633 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/008633
Camptothecin complexes Dec 7, 2004 Abandoned
Array ( [id] => 53248 [patent_doc_number] => 07772207 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-08-10 [patent_title] => 'Combination of a CDK inhibitor and CS-682 or a metabolite thereof' [patent_app_type] => utility [patent_app_number] => 10/581585 [patent_app_country] => US [patent_app_date] => 2004-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5713 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/772/07772207.pdf [firstpage_image] =>[orig_patent_app_number] => 10581585 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/581585
Combination of a CDK inhibitor and CS-682 or a metabolite thereof Dec 2, 2004 Issued
Array ( [id] => 7237862 [patent_doc_number] => 20050080041 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-04-14 [patent_title] => 'Method and composition for the treatment of adenoviral ocular infections' [patent_app_type] => utility [patent_app_number] => 10/997955 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3199 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20050080041.pdf [firstpage_image] =>[orig_patent_app_number] => 10997955 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/997955
Method and composition for the treatment of adenoviral ocular infections Nov 28, 2004 Issued
Array ( [id] => 168606 [patent_doc_number] => 07666905 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-23 [patent_title] => 'Compositions comprising hepoxilin analogs and their use in the treatment of cancer' [patent_app_type] => utility [patent_app_number] => 10/999195 [patent_app_country] => US [patent_app_date] => 2004-11-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 14 [patent_no_of_words] => 8234 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 27 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/666/07666905.pdf [firstpage_image] =>[orig_patent_app_number] => 10999195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/999195
Compositions comprising hepoxilin analogs and their use in the treatment of cancer Nov 28, 2004 Issued
Array ( [id] => 7597631 [patent_doc_number] => 07618946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-11-17 [patent_title] => 'Analgesic compounds, extracts containing same and methods of preparation' [patent_app_type] => utility [patent_app_number] => 10/580805 [patent_app_country] => US [patent_app_date] => 2004-11-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 35 [patent_figures_cnt] => 69 [patent_no_of_words] => 19690 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/618/07618946.pdf [firstpage_image] =>[orig_patent_app_number] => 10580805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/580805
Analgesic compounds, extracts containing same and methods of preparation Nov 25, 2004 Issued
Array ( [id] => 833655 [patent_doc_number] => 07396946 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Compound for treatment of external secretion disorders' [patent_app_type] => utility [patent_app_number] => 10/994364 [patent_app_country] => US [patent_app_date] => 2004-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9094 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 12 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396946.pdf [firstpage_image] =>[orig_patent_app_number] => 10994364 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994364
Compound for treatment of external secretion disorders Nov 22, 2004 Issued
Array ( [id] => 6959559 [patent_doc_number] => 20050215568 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-29 [patent_title] => 'Substituted oxetanes, method of making, and method of use thereof' [patent_app_type] => utility [patent_app_number] => 10/992805 [patent_app_country] => US [patent_app_date] => 2004-11-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11723 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0215/20050215568.pdf [firstpage_image] =>[orig_patent_app_number] => 10992805 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/992805
Substituted oxetanes, method of making, and method of use thereof Nov 18, 2004 Issued
Array ( [id] => 7111729 [patent_doc_number] => 20050209185 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 10/994030 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34199 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 36 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209185.pdf [firstpage_image] =>[orig_patent_app_number] => 10994030 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/994030
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases Nov 17, 2004 Abandoned
Array ( [id] => 7046135 [patent_doc_number] => 20050250730 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-11-10 [patent_title] => 'Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases' [patent_app_type] => utility [patent_app_number] => 10/991634 [patent_app_country] => US [patent_app_date] => 2004-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 34198 [patent_no_of_claims] => 42 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0250/20050250730.pdf [firstpage_image] =>[orig_patent_app_number] => 10991634 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/991634
Combination of an adenosine A2A-receptor agonist and tiotropium or a derivative thereof for treating obstructive airways and other inflammatory diseases Nov 17, 2004 Abandoned
Array ( [id] => 7249877 [patent_doc_number] => 20050142087 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Compositions containing silicone-in-water emulsions, salts, alcohols and solvents' [patent_app_type] => utility [patent_app_number] => 10/989847 [patent_app_country] => US [patent_app_date] => 2004-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6695 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20050142087.pdf [firstpage_image] =>[orig_patent_app_number] => 10989847 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/989847
Compositions containing silicone-in-water emulsions, salts, alcohols and solvents Nov 11, 2004 Abandoned
Array ( [id] => 5252731 [patent_doc_number] => 20070134187 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders' [patent_app_type] => utility [patent_app_number] => 10/577444 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 5904 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0134/20070134187.pdf [firstpage_image] =>[orig_patent_app_number] => 10577444 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/577444
Medicament comprising a reducing alkyl-sugar monomer for the treatment of inflammatory disorders Oct 28, 2004 Issued
Array ( [id] => 7011405 [patent_doc_number] => 20050065121 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-24 [patent_title] => 'Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters' [patent_app_type] => utility [patent_app_number] => 10/977752 [patent_app_country] => US [patent_app_date] => 2004-10-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 29453 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0065/20050065121.pdf [firstpage_image] =>[orig_patent_app_number] => 10977752 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977752
Methods to increase plasma HDL cholesterol levels and improve HDL functionality with probucol monoesters Oct 28, 2004 Abandoned
Array ( [id] => 5080265 [patent_doc_number] => 20070123489 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-05-31 [patent_title] => 'Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome' [patent_app_type] => utility [patent_app_number] => 10/974566 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 17873 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0123/20070123489.pdf [firstpage_image] =>[orig_patent_app_number] => 10974566 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/974566
Method and medicament for sulfated polysaccharide treatment of heparin-induced thrombocytopenia (HIT) syndrome Oct 26, 2004 Issued
Array ( [id] => 6966092 [patent_doc_number] => 20050232989 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-10-20 [patent_title] => 'Process for preparing oral calcium compositions' [patent_app_type] => utility [patent_app_number] => 10/973352 [patent_app_country] => US [patent_app_date] => 2004-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5971 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0232/20050232989.pdf [firstpage_image] =>[orig_patent_app_number] => 10973352 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/973352
Process for preparing oral calcium compositions Oct 26, 2004 Abandoned
Array ( [id] => 7257687 [patent_doc_number] => 20050143573 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-30 [patent_title] => 'Reduced malto-oligosaccharides' [patent_app_type] => utility [patent_app_number] => 10/963681 [patent_app_country] => US [patent_app_date] => 2004-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5468 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0143/20050143573.pdf [firstpage_image] =>[orig_patent_app_number] => 10963681 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/963681
Reduced malto-oligosaccharides Oct 12, 2004 Issued
Array ( [id] => 435923 [patent_doc_number] => 07262180 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-28 [patent_title] => 'Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye' [patent_app_type] => utility [patent_app_number] => 10/963848 [patent_app_country] => US [patent_app_date] => 2004-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7994 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/262/07262180.pdf [firstpage_image] =>[orig_patent_app_number] => 10963848 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/963848
Compositions and methods for the treatment of inflammatory conditions of mucosae, skin and the eye Oct 11, 2004 Issued
Array ( [id] => 5259749 [patent_doc_number] => 20070213381 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-09-13 [patent_title] => 'Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders' [patent_app_type] => utility [patent_app_number] => 10/575023 [patent_app_country] => US [patent_app_date] => 2004-10-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4415 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 12 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0213/20070213381.pdf [firstpage_image] =>[orig_patent_app_number] => 10575023 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/575023
Topical Compositions Comprising Telmesteine for Treating Dermatological Disorders Oct 6, 2004 Abandoned
Array ( [id] => 7110533 [patent_doc_number] => 20050207988 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'Polysaccharides for pulmonary delivery of active agents' [patent_app_type] => utility [patent_app_number] => 10/957218 [patent_app_country] => US [patent_app_date] => 2004-10-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 26814 [patent_no_of_claims] => 82 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20050207988.pdf [firstpage_image] =>[orig_patent_app_number] => 10957218 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/957218
Polysaccharides for pulmonary delivery of active agents Sep 30, 2004 Issued
Array ( [id] => 6939740 [patent_doc_number] => 20050113303 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-26 [patent_title] => 'Use of PEX in the treatment of metabolic bone diseases' [patent_app_type] => utility [patent_app_number] => 10/952878 [patent_app_country] => US [patent_app_date] => 2004-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 13958 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0113/20050113303.pdf [firstpage_image] =>[orig_patent_app_number] => 10952878 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/952878
Inhibition of PEX in the treatment of metabolic bone diseases Sep 29, 2004 Issued
Array ( [id] => 6918773 [patent_doc_number] => 20050096334 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-05-05 [patent_title] => 'Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome' [patent_app_type] => utility [patent_app_number] => 10/947967 [patent_app_country] => US [patent_app_date] => 2004-09-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4092 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0096/20050096334.pdf [firstpage_image] =>[orig_patent_app_number] => 10947967 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/947967
Use of substance P antagonists for the treatment of chronic fatigue syndrome and/or fibromyalgia and use of NK-1 receptor antagonists for the treatment of chronic fatigue syndrome Sep 22, 2004 Abandoned
Menu